|
|
ONCOLOGY NURSE
PRACTITIONER SKILL CHECK LIST
|
NAME
|
|
|
|
|
|
|
|
LAST 4 OF SSN
|
|
|
|
|
|
|
|
|
DATE
|
|
|
|
|
|
|
|
|
I hereby certify that
ALL information I have provided to IMCS Group on this skills checklist and
all other documentation, is true and accurate. I understand and acknowledge
that any misrepresentation or omission may result in disqualification from
employment and/or immediate termination.
|
|
|
|
Instructions: This checklist is
meant to serve as a general guideline for our client facilities as to the
level of your skills within your nursing specialty. Please use the scale
below to describe your experience/expertise in each area listed below.
|
|
Proficiency Scale:
|
1 = No Experience
2 = Need Training
3 = Able to perform with supervision
4 = Able to perform independently
|
|
|
|
|
|
Rating Stars (Click)
|
Comprehensive Health
Assessment
|
1
|
2
|
3
|
4
|
|
Demonstrates the
ability to perform initial health assessments that identify factors that will
impact the patient’s cancer chemotherapy experience, this may include:
|
|
|
Pre-existing health
problems including allergies, medication and any previous exposure to cancer
chemotherapy medications
|
|
|
|
|
|
|
Age and stage of
development
|
|
|
|
|
|
|
Psychosocial factors
|
|
|
|
|
|
Demonstrates the ability to perform ongoing health assessments
in a timely manner:
|
|
|
Before each chemotherapy
cycle
|
|
|
|
|
|
|
Before renewal of
self-administered and non- cyclical chemotherapy and biotherapy prescriptions
|
|
|
|
|
|
|
In
response to patient concerns &
When health status changes (physical, emotional, mental, spiritual,
cognitive, developmental, environmental)
|
|
|
|
|
|
|
When side effects occur
|
|
|
|
|
|
|
When evidence of an
adverse event/toxicity
|
|
|
|
|
|
Demonstrates the
ability to document assessments by BCHS policy and procedure as well as CNO
standards in the following applications:
|
|
|
Meditech
|
|
|
|
|
|
|
Opis
|
|
|
|
|
|
|
Mosaiq
|
|
|
|
|
|
|
Patient’s individualized
paper chart
|
|
|
|
|
|
|
Demonstrates
the ability to formulate a place of care in collaboration with the patient,
family and interprofessional care team to address issues
identified during assessments
|
|
|
|
|
|
Rating Stars
(Click)
|
Supportive and Therapeutic
Relationships
|
1
|
2
|
3
|
4
|
|
|
Demonstrates
the ability to consider the emotional, cultural, and spiritual context of
patients and families
during initial and ongoing care
|
|
|
|
|
|
|
Demonstrates
the ability to work collaboratively with the patient and family to identify
support services
needed to manage and initiate referrals as appropriate
|
|
|
|
|
|
|
Demonstrates
the ability to reflect on and monitor the therapeutic relationships that
evolve overtime, as
needs and outcomes change
|
|
|
|
|
|
|
Demonstrates
the ability to document the patient and family perspective to enable
individualized cancer chemotherapy and biotherapy care while
maintaining
confidentiality
|
|
|
|
|
|
|
Demonstrates
the ability to listen and explore the
patient and family concerns
|
|
|
|
|
|
Rating Stars
(Click)
|
Management of Cancer
Symptoms and Treatment Side Effects
|
1
|
2
|
3
|
4
|
|
Demonstrates the
ability to maintain and apply current knowledge, judgement and skill in the
management of chemotherapy and biotherapy side effects and toxicities related
to the specific population in which is practiced. This includes but not
limited to:
|
|
|
Neutropenia
|
|
|
|
|
|
|
Anemia
|
|
|
|
|
|
|
Peripheral neuropathies
and neurotoxicity
|
|
|
|
|
|
|
Thrombocytopenia
|
|
|
|
|
|
|
Hepatoxicity
|
|
|
|
|
|
|
Nephrotoxicity
|
|
|
|
|
|
|
Hemorrhagic cystitis
|
|
|
|
|
|
|
Cutaneous changes: nail
changes, rash, pigmentation alternations, hand-foot syndrome,
photosensitivity
|
|
|
|
|
|
|
Alopecia
|
|
|
|
|
|
|
Cardiac toxicity
|
|
|
|
|
|
|
Pulmonary toxicities
|
|
|
|
|
|
|
Cognitive changes
|
|
|
|
|
|
|
Psychosocial distress
|
|
|
|
|
|
|
Chemotherapy induced
nausea & vomiting
|
|
|
|
|
|
|
Anorexia & cachexia
|
|
|
|
|
|
|
Mucositis
|
|
|
|
|
|
|
Diarrhea
|
|
|
|
|
|
|
Constipation
|
|
|
|
|
|
|
Sleep disorders
|
|
|
|
|
|
|
Ocular toxicity
|
|
|
|
|
|
|
Fatigue
|
|
|
|
|
|
|
Sexuality and fertility
alterations
|
|
|
|
|
|
|
Infusion reactions
|
|
|
|
|
|
|
Extravasation and
infiltration
|
|
|
|
|
|
|
the
ability to communicate to members of the interdisciplinary team, the patient
and family to assist in developing care plans that address chemotherapy and
biotherapy side effects, toxicities, adverse events, and patient identified
concerns in a
timely manner
|
|
|
|
|
|
|
Demonstrates
an understanding of the principles, indications, classifications, and
mechanism of action for chemotherapies and biotherapies commonly
administered in the Cancer Clinic at BCHS
|
|
|
|
|
|
|
Applies
principles of safety and safe handling specific to the route and method of
chemotherapy and
biotherapy administration and the cytotoxic profile of the drugs
|
|
|
|
|
|
|
Applies
principles of safe handling to disposal of contaminated equipment and
cytotoxic agents, spill
management, and contaminated body fluids
|
|
|
|
|
|
Demonstrates
understanding of and utilizes principles of monitoring of patient during
blood and blood product transfusion:
|
|
|
PRBC
|
|
|
|
|
|
|
FFP
|
|
|
|
|
|
|
Platelets
|
|
|
|
|
|
|
Immune globulin
|
|
|
|
|
|
|
Albumin
|
|
|
|
|
|
|
Identifies blood
transfusion reactions and nursing responsibilities
|
|
|
|
|
|
Demonstrates the
ability to care for central venous access devices & peripherally inserted
central catheters (PICC):
|
|
|
Explain indication of use
and sites
|
|
|
|
|
|
|
States complications of
CVAD’s & PICC’s
|
|
|
|
|
|
|
Demonstrates
the skill to access CVAD’s for
intravenous therapy
|
|
|
|
|
|
Demonstrates the
skill to obtain blood sampling from:
|
|
|
Percutaneous CVAD
|
|
|
|
|
|
|
Implanted CVAD
|
|
|
|
|
|
|
Peripherally inserted
central catheter (PICC)
|
|
|
|
|
|
Rating Stars
(Click)
|
Teaching and Coaching
|
1
|
2
|
3
|
4
|
|
|
Demonstrates the ability
to assess the patient and family’s readiness to learn by evaluating age and
developmental level, existing knowledge level, their expectations for the
treatment and response to learning
|
|
|
|
|
|
|
Demonstrates
the ability to pace the teaching based
on the patient’s readiness to learn
|
|
|
|
|
|
Provides the patient and family with information specific to
their cancer treatment in relation to the following, based on best practice
guidelines, protocols and standards:
|
|
|
Purpose, mechanism of
action, route, and schedule of the treatment and supportive medication
|
|
|
|
|
|
|
Immediate, early, late and
delayed side effects and toxicities of treatment and their management,
differentiating between expected, non-urgent side effects and those that
require immediate medical attention
|
|
|
|
|
|
|
Safe use of mechanical
devices and equipment
|
|
|
|
|
|
|
Vascular access device
assessment and care
|
|
|
|
|
|
|
Safe handling of
contaminated equipment and body fluids
|
|
|
|
|
|
|
Requirements and rational
for monitoring parameters including bloodwork, diagnostic interventions, and
symptoms
|
|
|
|
|
|
|
Provides
patients and families with opportunities for reinforcement of the education
and validation of their
understanding
|
|
|
|
|
|
|
Evaluates
the outcomes of the education provided to
patients and families
|
|
|
|
|
|
|
Documents teaching
provided
|
|
|
|
|
|
|
Collaborates
with the healthcare team, including the pharmacist and physician, to provide
patient
education, share relevant findings and concerns
|
|
|
|
|
|
Rating Stars
(Click)
|
Facilitating Continuity of
Care/Navigating the System
|
1
|
2
|
3
|
4
|
|
|
Demonstrates
facilitation and advocacy for chemotherapy and biotherapy care to be provided
in the most appropriate setting along the cancer
continuum for the patient and family, with consideration given to their
needs
|
|
|
|
|
|
|
Facilitates processes that
enable patients and families to communicate with the appropriate members of
the health care team leading to access to resources and assistance when
needed. This process addresses who, when and how to communicate with the
health care team
|
|
|
|
|
|
|
Communicates
with healthcare providers at points of transition for the patient and family
to promote continuity of care and safety for the patient
|
|
|
|
|
|
|
Demonstrates ability to
assist patients and families to access comprehensive supportive care. This
includes psychosocial care, spiritual care, home care/CCAC and additional
care based on patient and family specific needs
|
|
|
|
|
|
Rating Stars
(Click)
|
Decision Making and
Advocacy
|
1
|
2
|
3
|
4
|
|
|
Demonstrates
providing information, education, and support to patients and families to
facilitate their decision making and autonomy in the informed
consent processes
|
|
|
|
|
|
|
Advocates for the
patient’s wishes and decisions in relation to their cancer chemotherapy care
|
|
|
|
|
|
Rating Stars
(Click)
|
Professional Practice and
Leadership
|
1
|
2
|
3
|
4
|
|
|
Recognizes
the limit of my competence and will only perform cancer chemotherapy
|
|
|
|
|
|
|
Collaborates
with healthcare professionals to make decisions about BCHS capacity to
provide safe chemotherapy and biotherapy services based on the level of
competence of involved healthcare professionals and clinical facilities
available
|
|
|
|
|
|
|
Seeks
out mentorship in areas where my expertise is limited
|
|
|
|
|
|
|
Provides
mentorship to novice nurses in areas in which I possess expertise
|
|
|
|
|
|
|
Demonstrates
use of research and evidence based knowledge to provide care to patients and
families
|
|
|
|
|
|
|
Participates
in professional oncology associations and professional practice groups to
further the practice of cancer chemotherapy and biotherapy nursing
|
|
|
|
|
|
|
Demonstrates
ability to recognize and critically analyse situations for potential ethical
and legal issues and apply ethical frameworks to support patients and
families decision making – accessing recourses as needed to assist in this
process
|
|
|
|
|
|
Rating Stars
(Click)
|
EMR
|
1
|
2
|
3
|
4
|
|
|
Epic
|
|
|
|
|
|
|
Cerner
|
|
|
|
|
|
|
Eclipsys
|
|
|
|
|
|
|
McKesson
|
|
|
|
|
|
|
Meditech
|
|
|
|
|
|
|
Other Computerized System
|
|
|
|
|
|
|
Computerized Physician
Order Entry
|
|
|
|
|
|
|
Bar Coding for Medication
Administration
|
|
|
|
|
|
MY EXPERIENCE
IS PRIMARILY IN:
|
|
|
|
|
|
|
|
Unit
|
No. of Years
|
Unit
|
No. of Years
|
|
BURN
|
|
POST
PARTUM
|
|
|
CRITICAL UNIT
|
|
LABOR
& DELIVERY
|
|
|
PACU
|
|
NEWBORN
NURSERY
|
|
|
NEUROLOGY
|
|
LEVEL
II NICU
|
|
|
TELEMETRY
|
|
LEVEL
III NICU
|
|
|
MEDICAL
|
|
PICU
|
|
|
SURGICAL
|
|
PEDIATRICS
|
|
|
ONCOLOGY
|
|
OB/GYN
|
|
|
ORTHOPEDICS
|
|
PSYCHIATRY
|
|
|
OPERATING ROOM
|
|
RRT
|
|
|
EMERGENCY ROOM
|
|
CRT
|
|
|
TRAUMA CENTER LEVEL 1
|
|
|
|
|
COMMUNITY ER
|
|
|
|
|
RURAL ER
|
|
|
|
|
Rating Stars
(Click)
|
Age Specific Competencies
|
1
|
2
|
3
|
4
|
|
|
Newborn/Neonatal (birth –
30 days)
|
|
|
|
|
|
|
Infant (30 days-1 year)
|
|
|
|
|
|
|
Toddler (1-3 years)
|
|
|
|
|
|
|
Preschool (3-5 years)
|
|
|
|
|
|
|
School Age Children (5-12
years)
|
|
|
|
|
|
|
Adolescent (12-17 years)
|
|
|
|
|
|
|
Young Adults (18-44 years)
|
|
|
|
|
|
|
Middle Adults (45-64
years)
|
|
|
|
|
|
|
Older Adults (>65
years)
|
|
|
|
|
|